Research Article
Thiopurines in the Management of Crohn’s Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study
Table 4
Between-group comparison of patients who maintained remission.
| Visit | Full dose () | Low dose () | value | Total number | Maintenance of remission | Total number | Maintenance of remission |
| 3 months, (%) | 52 | 27 (52%) | 20 | 8 (40%) | 0.4353 | 6 months, (%) | 35 | 19 (54%) | 18 | 7 (39%) | 0.3869 | 9 months, (%) | 29 | 13 (45%) | 18 | 8 (44%) | 1 | 12 months, (%) | 23 | 11 (48%) | 14 | 7 (50%) | 1 |
|
|